NBDC Research ID: hum0222.v1

 

SUMMARY

Aims: To clarify risk of germline variants of known causal genes for Hereditary Breast Ovarian Cancer Syndrome in Japan by combinatorial analysis of somatic and germline variants in the breast cancer tissue.

Methods: Target caputure analysis by using Illumina HiSeq 2000

Participants/Materials: 108 whole blood and 124 primary tumor samples from familial breast cancer patients

 

Dataset IDType of DataCriteriaRelease Date
JGAS000224 NGS (Target Capture) Controlled-access (Type I) 2020/03/13

*Release Note

* Data users need to apply an application for Using NBDC Human Data to reach the Controlled-access Data. Learn more

 

MOLECULAR DATA

JGAS000224

Participants/Materials

breast cancer (ICD10: C50): 115 cases (124 samples)

primary tumor tissues and paired blood: 108 cases (116 samples)

primary tumor tissues only: 7 cases (8 samples)

Targets Target Capture
Target Loci for Capture Methods 119 genes including known causal genes of HBOC syndrome
(BRCA1, BRCA2, STK11, NBN, ATM, CHEK2, PALB2,
TP53, PTEN, CDH1, RAD51D, RAD51C, BRIP1, RAD50,
XRCC2, RAD51B, NF1, EPCAM, MLH1, MSH2, MSH6,
PMS2, BARD1, MRE11A, FANCC, BLM, FAM175A,
RINT1, FANCM, RECQL
, etc.)
Platform Illumina [HiSeq 2000]
Library Source DNAs extracted from primary tumor tissues and peripheral blood cells
Cell Lines -
Library Construction (kit name) SureSelect XT Custom
Fragmentation Methods

blood 108 samples : Ultrasonic fragmentation (Covaris)

tumor 49 samples : Ultrasonic fragmentation (Covaris)

tumor 75 samples : Enzymatic fragmentation (DNase included in KAPA HyperPlus Kit)

Spot Type Paired-end
Read Length (without Barcodes, Adaptors, Primers, and Linkers) 101 bp
Japanese Genotype-phenotype Archive Dataset ID JGAD000315
Total Data Volume 222 GB (fastq)
Comments (Policies) NBDC policy

 

DATA PROVIDER

Principal Investigator: Shinji Ohno

Affiliation: The Cancer Institute Hospital of JFCR

Project / Group Name: -

Funds / Grants (Research Project Number):

NameTitleProject Number
Project for Cancer Research and Therapeutic Evolution (P-CREATE), Japan Agency for Medical Research and Development (AMED) Identification of responsible genes and development of standardized medicine for familial breast cancer by genetic analysis with NGS technology JP16cm0106503

 

PUBLICATIONS

TitleDOIDataset ID
1 Prevalence of disease-causing genes in Japanese patients with BRCA1/2-wildtype hereditary breast and ovarian cancer syndrome doi: 10.1038/s41523-020-0163-1 JGAD000315
2

 

USRES (Controlled-access Data)

Principal InvestigatorAffiliationCountry/RegionResearch TitleData in Use (Dataset ID)Period of Data Use